Research Grant in Memory of Peggy A. Yates supports researchers developing minimally invasive, accessible screening approaches to detect gynecologic cancers other than ovarian cancer earlier.
Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal)
Funding Amounts: $50,000 for one year
Summary: Supports minimally invasive, accessible, cost-effective approaches to early detection of gynecologic cancers other than ovarian cancer.
Key Information: Research must take place at a U.S. institution; full professors are ineligible.
The Foundation for Women's Cancer (FWC) offers this grant within its 2026–2027 Multi-Type Gynecologic Cancer Grants program, with support from the family of Peggy A. Yates. It funds innovative research advancing early detection of gynecologic cancers other than ovarian cancer through minimally invasive, accessible, and cost-effective approaches.
Priority is given to discovering and validating diagnostic biomarkers using readily obtainable biospecimens, including urine, vaginal or cervical samples, and blood, alongside emerging sampling technologies. The goal is to develop accurate, scalable screening strategies that enable earlier diagnosis and can be broadly implemented across diverse populations and care settings.